Limited Time Sale$267.59 cheaper than the new price!!
| Management number | 204569994 | Release Date | 2025/10/14 | List Price | $178.40 | Model Number | 204569994 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||

Laverdia-CA1 50mg Tablets are an FDA conditionally approved oral treatment for lymphoma in dogs, utilizing Verdinexor, a novel selective inhibitor of nuclear export (SINE) compound. Designed specifically for canine patients, Laverdia-CA1 works by disrupting the transport of cancer-driving proteins in lymphoma cells, leading to apoptosis (programmed cell death).
This prescription oral medication offers a less invasive alternative to injectable chemotherapy, giving pet owners a practical solution for managing lymphoma in dogs at home, under veterinary supervision.
Prescription items are NON-RETURNABLE and NON-REFUNDABLE.
NOTE: For generic medications, the product image shown may not reflect the actual item received. Generic medications can vary in size, color, and shape between orders depending on the manufacturer. Additionally, your medication may arrive packaged in a HardyPaw Pharmacy vial.
Also Available In
Shop Laverdia-CA1 in multiple strengths to match your dog’s treatment needs:
Laverdia-CA1 offers multiple clinical and quality-of-life advantages over traditional chemotherapy:
Buying Options and Discounts: Purchase Laverdia-CA1 in a convenient 3-week, 1, 2, 3, and 6-month supply pack. Subscribe for regular shipments to ensure you never miss a dose and enjoy discounts on your purchases.
Order online for hassle-free delivery to your doorstep.
Laverdia-CA1 contains Verdinexor, which blocks a cellular protein called Exportin 1 (XPO1). XPO1 is responsible for transporting tumor-suppressor proteins out of the nucleus. By inhibiting this process:
Verdinexor belongs to the class of Selective Inhibitors of Nuclear Export (SINE) – a revolutionary drug class in veterinary oncology.
Always consult your veterinarian for exact dosage instructions depending on your pet's condition.
Important: Dosing is based on your dog’s body weight. Your vet will prescribe the appropriate strength and number of tablets.
|
Ingredient |
Purpose |
|
Verdinexor |
Selective Inhibitor of Nuclear Export (SINE); targets cancer cell replication |
Inactive Ingredients: Microcrystalline cellulose, magnesium stearate, lactose monohydrate, sodium starch glycolate (may vary slightly per manufacturer formulation).
While generally well tolerated, Laverdia-CA1 may cause mild to moderate side effects in some dogs, especially during early treatment:
Most side effects are self-limiting. In case of persistent or severe symptoms, consult your vet immediately.
Laverdia-CA1 is ideal for:
Always discuss treatment options, expected outcomes, and monitoring plans with your veterinarian.
Shipping Policy: HardyPaw offer all types of shipping options (Ground, Express, Priority, International) depending on the urgency of the product requirements. To know about our shipping policy in detail, click here.
Refund policy: If you face any issue with our product and want to return it, read our refund policy carefully.
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form